Do analysts prefer MCTA or VRDN?

Viridian Therapeutics has a consensus price target of $38.79, indicating a potential upside of 102.33%. Given Viridian Therapeutics' stronger consensus rating and higher probable upside, analysts clearly believe Viridian Therapeutics is more favorable than Charming Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Charming Medical 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Viridian Therapeutics 1 Sell rating(s) 0 Hold rating(s) 13 Buy rating(s) 0 Strong Buy rating(s) 2.86

Which has preferable valuation and earnings, MCTA or VRDN?

Charming Medical has higher earnings, but lower revenue than Viridian Therapeutics. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Charming Medical N/A N/A N/A N/A N/A Viridian Therapeutics $70.85M 27.89 -$342.60M -$3.32 N/A

Do analysts prefer MCTA or AGL?

Agilon Health has a consensus price target of $64.00, suggesting a potential downside of 46.85%. Given Agilon Health's stronger consensus rating and higher probable upside, analysts clearly believe Agilon Health is more favorable than Charming Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Charming Medical 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Agilon Health 2 Sell rating(s) 7 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.21

Which has better earnings and valuation, MCTA or AGL?

Charming Medical has higher earnings, but lower revenue than Agilon Health. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Charming Medical N/A N/A N/A N/A N/A Agilon Health $5.93B 0.34 -$391.35M -$21.56 N/A

Do analysts recommend MCTA or SNDA?

Sonida Senior Living has a consensus target price of $41.25, indicating a potential upside of 2.95%. Given Sonida Senior Living's stronger consensus rating and higher probable upside, analysts plainly believe Sonida Senior Living is more favorable than Charming Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Charming Medical 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Sonida Senior Living 1 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.20

Which has better valuation & earnings, MCTA or SNDA?

Charming Medical has higher earnings, but lower revenue than Sonida Senior Living. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Charming Medical N/A N/A N/A N/A N/A Sonida Senior Living $381.14M 4.98 -$70.78M -$5.83 N/A

Do analysts recommend WGS or MCTA?

GeneDx currently has a consensus target price of $87.43, suggesting a potential upside of 39.66%. Given GeneDx's stronger consensus rating and higher possible upside, research analysts clearly believe GeneDx is more favorable than Charming Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score GeneDx 2 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.56 Charming Medical 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better earnings and valuation, WGS or MCTA?

Charming Medical has lower revenue, but higher earnings than GeneDx. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio GeneDx $427.54M 4.35 -$21.02M -$2.68 N/A Charming Medical N/A N/A N/A N/A N/A

Do analysts recommend MCTA or TDOC?

Teladoc Health has a consensus target price of $7.73, indicating a potential downside of 13.25%. Given Teladoc Health's stronger consensus rating and higher possible upside, analysts plainly believe Teladoc Health is more favorable than Charming Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Charming Medical 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Teladoc Health 1 Sell rating(s) 11 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.24

Which has better earnings and valuation, MCTA or TDOC?

Charming Medical has higher earnings, but lower revenue than Teladoc Health. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Charming Medical N/A N/A N/A N/A N/A Teladoc Health $2.53B 0.64 -$200.32M -$0.97 N/A

Charming Medical (MCTA) Competitors

$29.36 -0.01 (-0.02%)

As of 07/21/2026

Compare

MCTA vs. VRDN, AGL, SNDA, WGS, and TDOC

Should you buy Charming Medical stock or one of its competitors? MarketBeat compares Charming Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Charming Medical include Viridian Therapeutics (VRDN), Agilon Health (AGL), Sonida Senior Living (SNDA), GeneDx (WGS), and Teladoc Health (TDOC). These companies are all part of the "healthcare" industry.

How does Charming Medical compare to Viridian Therapeutics?

Charming Medical (NASDAQ:MCTA) and Viridian Therapeutics (NASDAQ:VRDN) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, analyst recommendations, valuation, profitability, earnings, dividends and risk.

Viridian Therapeutics has a consensus price target of $38.79, indicating a potential upside of 102.33%. Given Viridian Therapeutics' stronger consensus rating and higher probable upside, analysts clearly believe Viridian Therapeutics is more favorable than Charming Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Charming Medical	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Viridian Therapeutics	1 Sell rating(s)	0 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.86

Charming Medical has a net margin of 0.00% compared to Viridian Therapeutics' net margin of -490.31%. Charming Medical's return on equity of 0.00% beat Viridian Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Charming Medical	N/A	N/A	N/A
Viridian Therapeutics	-490.31%	-80.19%	-48.84%

Charming Medical has higher earnings, but lower revenue than Viridian Therapeutics.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Charming Medical	N/A	N/A	N/A	N/A	N/A
Viridian Therapeutics	$70.85M	27.89	-$342.60M	-$3.32	N/A

In the previous week, Viridian Therapeutics had 3 more articles in the media than Charming Medical. MarketBeat recorded 3 mentions for Viridian Therapeutics and 0 mentions for Charming Medical. Viridian Therapeutics' average media sentiment score of 0.58 beat Charming Medical's score of 0.00 indicating that Viridian Therapeutics is being referred to more favorably in the news media.

Company	Overall Sentiment
Charming Medical	Neutral
Viridian Therapeutics	Positive

Summary

Viridian Therapeutics beats Charming Medical on 6 of the 9 factors compared between the two stocks.

How does Charming Medical compare to Agilon Health?

Charming Medical (NASDAQ:MCTA) and Agilon Health (NYSE:AGL) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, media sentiment, risk, earnings, institutional ownership, analyst recommendations, valuation and profitability.

Charming Medical has higher earnings, but lower revenue than Agilon Health.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Charming Medical	N/A	N/A	N/A	N/A	N/A
Agilon Health	$5.93B	0.34	-$391.35M	-$21.56	N/A

Charming Medical has a net margin of 0.00% compared to Agilon Health's net margin of -6.09%. Charming Medical's return on equity of 0.00% beat Agilon Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Charming Medical	N/A	N/A	N/A
Agilon Health	-6.09%	-146.03%	-24.55%

In the previous week, Agilon Health had 4 more articles in the media than Charming Medical. MarketBeat recorded 4 mentions for Agilon Health and 0 mentions for Charming Medical. Agilon Health's average media sentiment score of 0.23 beat Charming Medical's score of 0.00 indicating that Agilon Health is being referred to more favorably in the news media.

Company	Overall Sentiment
Charming Medical	Neutral
Agilon Health	Neutral

Agilon Health has a consensus price target of $64.00, suggesting a potential downside of 46.85%. Given Agilon Health's stronger consensus rating and higher probable upside, analysts clearly believe Agilon Health is more favorable than Charming Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Charming Medical	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Agilon Health	2 Sell rating(s)	7 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.21

Summary

Agilon Health beats Charming Medical on 6 of the 9 factors compared between the two stocks.

How does Charming Medical compare to Sonida Senior Living?

Charming Medical (NASDAQ:MCTA) and Sonida Senior Living (NYSE:SNDA) are both small-cap services companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, earnings, risk, profitability, media sentiment, analyst recommendations, institutional ownership and valuation.

Charming Medical has a net margin of 0.00% compared to Sonida Senior Living's net margin of -24.15%. Charming Medical's return on equity of 0.00% beat Sonida Senior Living's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Charming Medical	N/A	N/A	N/A
Sonida Senior Living	-24.15%	-36.98%	-7.08%

Sonida Senior Living has a consensus target price of $41.25, indicating a potential upside of 2.95%. Given Sonida Senior Living's stronger consensus rating and higher probable upside, analysts plainly believe Sonida Senior Living is more favorable than Charming Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Charming Medical	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Sonida Senior Living	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20

87.6% of Sonida Senior Living shares are owned by institutional investors. 39.3% of Sonida Senior Living shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, Sonida Senior Living had 1 more articles in the media than Charming Medical. MarketBeat recorded 1 mentions for Sonida Senior Living and 0 mentions for Charming Medical. Sonida Senior Living's average media sentiment score of 0.69 beat Charming Medical's score of 0.00 indicating that Sonida Senior Living is being referred to more favorably in the news media.

Company	Overall Sentiment
Charming Medical	Neutral
Sonida Senior Living	Positive

Charming Medical has higher earnings, but lower revenue than Sonida Senior Living.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Charming Medical	N/A	N/A	N/A	N/A	N/A
Sonida Senior Living	$381.14M	4.98	-$70.78M	-$5.83	N/A

Summary

Sonida Senior Living beats Charming Medical on 8 of the 11 factors compared between the two stocks.

How does Charming Medical compare to GeneDx?

GeneDx (NASDAQ:WGS) and Charming Medical (NASDAQ:MCTA) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, earnings, dividends, media sentiment, analyst recommendations, institutional ownership, risk and valuation.

Charming Medical has a net margin of 0.00% compared to GeneDx's net margin of -17.58%. GeneDx's return on equity of 9.15% beat Charming Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
GeneDx	-17.58%	9.15%	5.21%
Charming Medical	N/A	N/A	N/A

61.7% of GeneDx shares are held by institutional investors. 25.2% of GeneDx shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Charming Medical has lower revenue, but higher earnings than GeneDx.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
GeneDx	$427.54M	4.35	-$21.02M	-$2.68	N/A
Charming Medical	N/A	N/A	N/A	N/A	N/A

In the previous week, GeneDx had 33 more articles in the media than Charming Medical. MarketBeat recorded 33 mentions for GeneDx and 0 mentions for Charming Medical. GeneDx's average media sentiment score of 0.21 beat Charming Medical's score of 0.00 indicating that GeneDx is being referred to more favorably in the media.

Company	Overall Sentiment
GeneDx	Neutral
Charming Medical	Neutral

GeneDx currently has a consensus target price of $87.43, suggesting a potential upside of 39.66%. Given GeneDx's stronger consensus rating and higher possible upside, research analysts clearly believe GeneDx is more favorable than Charming Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
GeneDx	2 Sell rating(s)	0 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.56
Charming Medical	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

GeneDx beats Charming Medical on 10 of the 11 factors compared between the two stocks.

How does Charming Medical compare to Teladoc Health?

Charming Medical (NASDAQ:MCTA) and Teladoc Health (NYSE:TDOC) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, earnings, analyst recommendations, media sentiment, valuation, profitability, dividends and institutional ownership.

76.8% of Teladoc Health shares are held by institutional investors. 0.7% of Teladoc Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Charming Medical has a net margin of 0.00% compared to Teladoc Health's net margin of -6.81%. Charming Medical's return on equity of 0.00% beat Teladoc Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Charming Medical	N/A	N/A	N/A
Teladoc Health	-6.81%	-11.45%	-5.54%

In the previous week, Teladoc Health had 5 more articles in the media than Charming Medical. MarketBeat recorded 5 mentions for Teladoc Health and 0 mentions for Charming Medical. Teladoc Health's average media sentiment score of 0.41 beat Charming Medical's score of 0.00 indicating that Teladoc Health is being referred to more favorably in the news media.

Company	Overall Sentiment
Charming Medical	Neutral
Teladoc Health	Neutral

Teladoc Health has a consensus target price of $7.73, indicating a potential downside of 13.25%. Given Teladoc Health's stronger consensus rating and higher possible upside, analysts plainly believe Teladoc Health is more favorable than Charming Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Charming Medical	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Teladoc Health	1 Sell rating(s)	11 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.24

Charming Medical has higher earnings, but lower revenue than Teladoc Health.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Charming Medical	N/A	N/A	N/A	N/A	N/A
Teladoc Health	$2.53B	0.64	-$200.32M	-$0.97	N/A

Summary

Teladoc Health beats Charming Medical on 8 of the 11 factors compared between the two stocks.

Get Charming Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MCTA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

MCTA vs. The Competition

Export

Metric	Charming Medical	Services – Health Industry	Services Sector	NASDAQ Exchange
Market Cap	$497.21M	$2.02B	$18.38B	$12.68B
Dividend Yield	N/A	N/A	5.12%	9.42%
P/E Ratio	N/A	26.38	18.70	23.95
Price / Sales	N/A	6.80	37.11	115.11
Price / Cash	N/A	2,138.07	361.92	60.45
Price / Book	N/A	29.57	12.01	6.16
Net Income	N/A	-$30.36M	-$15.57M	$331.73M
7 Day Performance	N/A	10.09%	-1.26%	-0.92%
1 Month Performance	N/A	15.32%	-2.86%	-2.23%
1 Year Performance	N/A	N/A	-27.11%	14.79%

Charming Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
MCTA Charming Medical	N/A	$29.36 0.0%	N/A	N/A	$497.21M	N/A	N/A	49	High Trading Volume
VRDN Viridian Therapeutics	3.4213 of 5 stars	$19.08 +0.5%	$38.79 +103.3%	+13.0%	$1.96B	$70.85M	N/A	50	Analyst Upgrade
AGL Agilon Health	1.2745 of 5 stars	$121.67 +5.0%	$64.00 -47.4%	+119.4%	$1.93B	$5.93B	N/A	1,076	News Coverage
SNDA Sonida Senior Living	1.8039 of 5 stars	$40.02 -0.6%	$41.25 +3.1%	N/A	$1.91B	$381.14M	N/A	5,140	News Coverage
WGS GeneDx	4.1766 of 5 stars	$62.43 -2.2%	$87.43 +40.0%	-22.6%	$1.90B	$427.54M	N/A	1,300	Trending News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:MCTA) was last updated on 7/23/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Charming Medical (MCTA) Competitors

MCTA vs. VRDN, AGL, SNDA, WGS, and TDOC

How does Charming Medical compare to Viridian Therapeutics?

Summary

How does Charming Medical compare to Agilon Health?

Summary

How does Charming Medical compare to Sonida Senior Living?

Summary

How does Charming Medical compare to GeneDx?

Summary

How does Charming Medical compare to Teladoc Health?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MCTA vs. The Competition

Charming Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Charming Medical (MCTA) Competitors

MCTA vs. VRDN, AGL, SNDA, WGS, and TDOC

How does Charming Medical compare to Viridian Therapeutics?

Do analysts prefer MCTA or VRDN?

Is MCTA or VRDN more profitable?

Which has preferable valuation and earnings, MCTA or VRDN?

Does the media favor MCTA or VRDN?

Summary

How does Charming Medical compare to Agilon Health?

Which has better earnings and valuation, MCTA or AGL?

Is MCTA or AGL more profitable?

Does the media refer more to MCTA or AGL?

Do analysts prefer MCTA or AGL?

Summary

How does Charming Medical compare to Sonida Senior Living?

Is MCTA or SNDA more profitable?

Do analysts recommend MCTA or SNDA?

Do institutionals & insiders have more ownership in MCTA or SNDA?

Does the media refer more to MCTA or SNDA?

Which has better valuation & earnings, MCTA or SNDA?

Summary

How does Charming Medical compare to GeneDx?

Is WGS or MCTA more profitable?

Do insiders and institutionals have more ownership in WGS or MCTA?

Which has better earnings and valuation, WGS or MCTA?

Does the media prefer WGS or MCTA?

Do analysts recommend WGS or MCTA?

Summary

How does Charming Medical compare to Teladoc Health?

Do insiders & institutionals have more ownership in MCTA or TDOC?

Is MCTA or TDOC more profitable?

Does the media refer more to MCTA or TDOC?

Do analysts recommend MCTA or TDOC?

Which has better earnings and valuation, MCTA or TDOC?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MCTA vs. The Competition

Charming Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools